Cite
Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development.
MLA
Hau, Raymond K., et al. “Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development.” Clinical Pharmacology & Therapeutics, vol. 114, no. 4, Oct. 2023, pp. 780–94. EBSCOhost, https://doi.org/10.1002/cpt.2984.
APA
Hau, R. K., Wright, S. H., & Cherrington, N. J. (2023). Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development. Clinical Pharmacology & Therapeutics, 114(4), 780–794. https://doi.org/10.1002/cpt.2984
Chicago
Hau, Raymond K., Stephen H. Wright, and Nathan J. Cherrington. 2023. “Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development.” Clinical Pharmacology & Therapeutics 114 (4): 780–94. doi:10.1002/cpt.2984.